Autopsy report · NCT00741767
The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD
Cause of deathSlow enrollment
“Study subject enrollment difficulties”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Obstructive Pulmonary Disease; Sleep Disorders
- Interventions
- salmeterol-fluticasone
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Clinical Trial With Mesalamine 1g Suppositories
“Enrollment difficulties” - Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
“Difficulties of enrollment” - Ultrasound Guided vs Unguided Intra-articular Knee Injections
“Difficulty enrolling subjects” - Maintenance Dosing of Vitamin D in Crohn's Disease
“Difficulties with enrollment” - Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
“difficulty in enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.